202 related articles for article (PubMed ID: 36059816)
1. Strategies for the induction of anti-inflammatory mesenchymal stem cells and their application in the treatment of immune-related nephropathy.
Zhou C; Bai XY
Front Med (Lausanne); 2022; 9():891065. PubMed ID: 36059816
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal stem cell 1 (MSC1)-based therapy attenuates tumor growth whereas MSC2-treatment promotes tumor growth and metastasis.
Waterman RS; Henkle SL; Betancourt AM
PLoS One; 2012; 7(9):e45590. PubMed ID: 23029122
[TBL] [Abstract][Full Text] [Related]
3. New Cell-Based Therapy Paradigm: Induction of Bone Marrow-Derived Multipotent Mesenchymal Stromal Cells into Pro-Inflammatory MSC1 and Anti-inflammatory MSC2 Phenotypes.
Betancourt AM
Adv Biochem Eng Biotechnol; 2013; 130():163-97. PubMed ID: 22869086
[TBL] [Abstract][Full Text] [Related]
4. Chlorzoxazone, a small molecule drug, augments immunosuppressive capacity of mesenchymal stem cells via modulation of FOXO3 phosphorylation.
Deng L; Li H; Su X; Zhang Y; Xu H; Fan L; Fan J; Han Q; Bai X; Zhao RC
Cell Death Dis; 2020 Mar; 11(3):158. PubMed ID: 32123161
[TBL] [Abstract][Full Text] [Related]
5. Time-dependent LPS exposure commands MSC immunoplasticity through TLR4 activation leading to opposite therapeutic outcome in EAE.
Kurte M; Vega-Letter AM; Luz-Crawford P; Djouad F; Noël D; Khoury M; Carrión F
Stem Cell Res Ther; 2020 Sep; 11(1):416. PubMed ID: 32988406
[TBL] [Abstract][Full Text] [Related]
6. A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype.
Waterman RS; Tomchuck SL; Henkle SL; Betancourt AM
PLoS One; 2010 Apr; 5(4):e10088. PubMed ID: 20436665
[TBL] [Abstract][Full Text] [Related]
7. The immunomodulatory function of equine MSCs is enhanced by priming through an inflammatory microenvironment or TLR3 ligand.
Cassano JM; Schnabel LV; Goodale MB; Fortier LA
Vet Immunol Immunopathol; 2018 Jan; 195():33-39. PubMed ID: 29249315
[TBL] [Abstract][Full Text] [Related]
8. The effect of pro-inflammatory cytokines on immunophenotype, differentiation capacity and immunomodulatory functions of human mesenchymal stem cells.
Pourgholaminejad A; Aghdami N; Baharvand H; Moazzeni SM
Cytokine; 2016 Sep; 85():51-60. PubMed ID: 27288632
[TBL] [Abstract][Full Text] [Related]
9. TNFα/TNFR2 signaling pathway: an active immune checkpoint for mesenchymal stem cell immunoregulatory function.
Beldi G; Khosravi M; Abdelgawad ME; Salomon BL; Uzan G; Haouas H; Naserian S
Stem Cell Res Ther; 2020 Jul; 11(1):281. PubMed ID: 32669116
[TBL] [Abstract][Full Text] [Related]
10. Netrin-1 prolongs skin graft survival by inducing the transformation of mesenchymal stem cells from pro-rejection to immune-tolerant phenotype.
Liu LP; Chen W; Fan Y; Qi BY; Wang Z; Shi BY
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8741-8750. PubMed ID: 31696460
[TBL] [Abstract][Full Text] [Related]
11. Human Umbilical Cord Mesenchymal Stem Cells: Subpopulations and Their Difference in Cell Biology and Effects on Retinal Degeneration in RCS Rats.
Wang L; Li P; Tian Y; Li Z; Lian C; Ou Q; Jin C; Gao F; Xu JY; Wang J; Wang F; Zhang J; Zhang J; Li W; Tian H; Lu L; Xu GT
Curr Mol Med; 2017; 17(6):421-435. PubMed ID: 29210653
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal stem cell therapy for the treatment of inflammatory diseases: Challenges, opportunities, and future perspectives.
Regmi S; Pathak S; Kim JO; Yong CS; Jeong JH
Eur J Cell Biol; 2019 Dec; 98(5-8):151041. PubMed ID: 31023504
[TBL] [Abstract][Full Text] [Related]
13. Regulatory-compliant conditions during cell product manufacturing enhance in vitro immunomodulatory properties of infrapatellar fat pad-derived mesenchymal stem/stromal cells.
Kouroupis D; Bowles AC; Greif DN; Leñero C; Best TM; Kaplan LD; Correa D
Cytotherapy; 2020 Nov; 22(11):677-689. PubMed ID: 32723596
[TBL] [Abstract][Full Text] [Related]
14. Molecular Mechanisms Responsible for Anti-inflammatory and Immunosuppressive Effects of Mesenchymal Stem Cell-Derived Factors.
Harrell CR; Jankovic MG; Fellabaum C; Volarevic A; Djonov V; Arsenijevic A; Volarevic V
Adv Exp Med Biol; 2019; 1084():187-206. PubMed ID: 31175638
[TBL] [Abstract][Full Text] [Related]
15. Immunosuppressive properties of mesenchymal stem cells: advances and applications.
De Miguel MP; Fuentes-Julián S; Blázquez-Martínez A; Pascual CY; Aller MA; Arias J; Arnalich-Montiel F
Curr Mol Med; 2012 Jun; 12(5):574-91. PubMed ID: 22515979
[TBL] [Abstract][Full Text] [Related]
16. The Immunomodulatory Effects of Mesenchymal Stem Cells on Regulatory B Cells.
Liu J; Liu Q; Chen X
Front Immunol; 2020; 11():1843. PubMed ID: 32922398
[TBL] [Abstract][Full Text] [Related]
17. The Immunomodulatory Potential of Mesenchymal Stem Cells in a Retinal Inflammatory Environment.
Hermankova B; Kossl J; Bohacova P; Javorkova E; Hajkova M; Krulova M; Zajicova A; Holan V
Stem Cell Rev Rep; 2019 Dec; 15(6):880-891. PubMed ID: 31863334
[TBL] [Abstract][Full Text] [Related]
18. Molecular Crosstalk Between Macrophages and Mesenchymal Stromal Cells.
Stevens HY; Bowles AC; Yeago C; Roy K
Front Cell Dev Biol; 2020; 8():600160. PubMed ID: 33363157
[TBL] [Abstract][Full Text] [Related]
19. Robust In Vitro and In Vivo Immunosuppressive and Anti-inflammatory Properties of Inducible Caspase-9-mediated Apoptotic Mesenchymal Stromal/Stem Cell.
Romecín PA; Vinyoles M; López-Millán B; de la Guardia RD; Atucha NM; Querol S; Bueno C; Benitez R; Gonzalez-Rey E; Delgado M; Menéndez P
Stem Cells Transl Med; 2022 Mar; 11(1):88-96. PubMed ID: 35641173
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-146a-5p-modified human umbilical cord mesenchymal stem cells enhance protection against diabetic nephropathy in rats through facilitating M2 macrophage polarization.
Zhang Y; Le X; Zheng S; Zhang K; He J; Liu M; Tu C; Rao W; Du H; Ouyang Y; Li C; Wu D
Stem Cell Res Ther; 2022 Apr; 13(1):171. PubMed ID: 35477552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
